Patent ReferencesRecombinant DNA process utilizing a papilloma virus DNA as a vector Methods for the in vitro detection and identification of unknown pathogens or genetic entities Patent #: 4652517 InventorsAssigneeApplicationNo. 257198 filed on 10/13/1988US Classes:435/6, Involving nucleic acid435/810, PACKAGED DEVICE OR KIT436/501, BIOSPECIFIC LIGAND BINDING ASSAY436/504, Radioactive label436/527, Glass or silica436/528, Carrier is organic536/24.3Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNAExaminersPrimary: Warden, Robert J.Assistant: Wagner, Richard Attorney, Agent or FirmInternational ClassesC12N 015/00G01N 033/566 G01N 033/552 AbstractImproved methodologies for in-situ hybridization and detection of hybridized nucleic acid sequences in cell cultures and tissue sections are provided which offer an increase of speed, sensitivity, and simplicity unavailable in previously known techniques. The invention detects specific nucleic acids of interest, particularly RNA sequences, within cells and tissues utilizing DNA of a particular size as a probe to find those sequences which are held substantially in common between the cell or tissue and the probe. The cells are fixed preferably in paraformaldehyde and then hybridized using a hybridization fluid for not less than 10 minutes but not substantially more than 24 hours. A variety of identifying labels are attached to the probe which permit quick and rapid detection via measurement of radioactive isotope decay or by colorimetric detection of enzymatic reaction products. The invention is intended for use as a diagnostic kit in clinical/diagnostic laboratory testing facilities in that it permits a relatively unskilled person to accurately and reproducibly detect a few molecules of a specific nucleic acid of interest in-situ in 10 minutes.Other References
Field of SearchInvolving virus or bacteriophage |
| ||||||||||||||